Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

doctor.jpg

An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events. 

A structural heart Presentation during the TVT 2022 conference. #TCT #TCT22 #TCT2022

The Cardiovascular Research Foundation (CRF) announced the 32 late-breaking studies being presented at the Transcatheter Cardiovascular Therapeutics 2022 annual meeting at in Boston, Sept. 16-19.

This latest shortage involves dobutamine, an injectable medication often prescribed for advanced heart failure and cardiogenic shock. It is also a central component of dobutamine stress echocardiography (DSE), a test used to evaluate patients with severe aortic stenosis.

The shortage could lead to significant issues for cardiologists. The American College of Cardiology provided some words of wisdom on the ongoing issue.  

anticoagulation UNC Charlotte RNA DNA

“We can learn from nature, but we have built something that has never been introduced before,” one researcher said. 

The four-year analysis will use cardiac MRI scans to closely monitor the heart health of people living with HIV who regularly use cannabis to treat their symptoms. 

The new meta-analysis included data from nearly 10,000 patients. 

The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting. #AMA #AMA175 #AMAmtg #ASNC

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.

Continuous and high-adherent statin users had lower baseline arterial stiffness, which also grew more slowly over time. 

Laboratory

The study's authors hope their equations can make a significant impact on patient care in the years ahead. 

Elderly patient doctor

Researchers examined the clinical impact of treating valvular AFib with dabigatran instead of warfarin. 

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

Around the web

Two companies serving medical imagers just had products cleared for marketing in the U.S.

Defendants in the case allegedly defrauded CMS for millions of dollars that were spent on luxury vehicles, real estate and more.

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

   
   
   
   
   
Trimed Popup
Trimed Popup